Dimensional Fund Advisors LP Lowers Holdings in Ingevity Co. (NYSE:NGVT)

Dimensional Fund Advisors LP lowered its stake in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 4.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 793,423 shares of the company's stock after selling 39,289 shares during the quarter. Dimensional Fund Advisors LP owned 2.18% of Ingevity worth $32,331,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of NGVT. KBC Group NV lifted its position in shares of Ingevity by 27.5% during the 4th quarter. KBC Group NV now owns 2,007 shares of the company's stock valued at $82,000 after buying an additional 433 shares during the last quarter. Empowered Funds LLC purchased a new stake in Ingevity during the 4th quarter worth about $187,000. O Shaughnessy Asset Management LLC purchased a new stake in Ingevity during the 4th quarter worth about $214,000. Teacher Retirement System of Texas purchased a new stake in Ingevity during the 4th quarter worth about $237,000. Finally, Hennion & Walsh Asset Management Inc. purchased a new stake in Ingevity during the 4th quarter worth about $239,000. Institutional investors own 91.59% of the company's stock.

Ingevity Stock Up 0.4%

Shares of NGVT traded up $0.17 on Friday, reaching $40.46. The stock had a trading volume of 260,803 shares, compared to its average volume of 278,867. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of -3.42 and a beta of 1.31. The company has a debt-to-equity ratio of 6.86, a quick ratio of 1.04 and a current ratio of 1.87. The company has a 50-day simple moving average of $37.49 and a 200-day simple moving average of $41.97. Ingevity Co. has a 12-month low of $28.49 and a 12-month high of $56.28.

Ingevity (NYSE:NGVT - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.25. The business had revenue of $284.00 million during the quarter, compared to analysts' expectations of $299.13 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The firm's quarterly revenue was down 16.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.47 earnings per share. Sell-side analysts predict that Ingevity Co. will post 4.45 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on NGVT. StockNews.com cut Ingevity from a "buy" rating to a "hold" rating in a report on Saturday, April 12th. Wells Fargo & Company increased their price objective on Ingevity from $32.00 to $38.00 and gave the stock an "equal weight" rating in a report on Wednesday. Finally, BMO Capital Markets raised Ingevity from a "market perform" rating to an "outperform" rating and raised their price target for the company from $62.00 to $65.00 in a report on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $52.75.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.